702 filings
Page 4 of 36
8-K
b36 l88pweo
19 Oct 22
ISS, Glass Lewis and Egan-Jones Recommend that Acorda Stockholders Vote FOR the Proposal to Implement a Reverse Stock Split
4:05pm
8-K
wfhxzdonzqgci3un
18 Oct 22
Other Events
1:00pm
8-K
gg96mgu
17 Oct 22
Acorda Therapeutics Announces $16.5M Award and Royalty/Supply Relief in AMPYRA® Arbitration Case
9:00am
DEFA14A
5e6ojrz9q n5tnb3e
11 Oct 22
Additional proxy soliciting materials
4:18pm
DEFA14A
fjdav3q0
11 Oct 22
Additional proxy soliciting materials
4:16pm
DEFA14A
45z43f xmei
11 Oct 22
Additional proxy soliciting materials
9:27am
8-K
h1muq8
11 Oct 22
Acorda Therapeutics Withdraws Proposal to Increase Authorized Shares from Special Meeting of Stockholders
9:26am
DEFA14A
mc07 op440tti17
7 Oct 22
Additional proxy soliciting materials
5:12pm
DEFA14A
4arfavhn0b9no
7 Oct 22
Additional proxy soliciting materials
5:11pm
DEFA14A
fyujdn 40i433d
7 Oct 22
Additional proxy soliciting materials
5:11pm
DEFA14A
hja5whg2ia48 coz6ie0
7 Oct 22
Additional proxy soliciting materials
5:10pm
DEFA14A
ne85xc5p3
7 Oct 22
Additional proxy soliciting materials
4:06pm
DEFA14A
ty9nevz3aa bfruhyl8
3 Oct 22
Additional proxy soliciting materials
4:16pm
DEFA14A
mq1xtksf
3 Oct 22
Additional proxy soliciting materials
4:13pm
DEFA14A
0o6kse6j9ah vebq
3 Oct 22
Additional proxy soliciting materials
12:01pm
DEFA14A
jnbvxz
22 Sep 22
Additional proxy soliciting materials
4:07pm
8-K
lm70aj bwj7zn9
30 Aug 22
Acorda Therapeutics Enters into License Agreement with Asieris Pharmaceuticals
8:01am
8-K
owhonvfgws7m
19 Aug 22
Acorda Therapeutics Announces Resignation of
8:14am